España
India
Italia
대한민국
日本
My Account
My Account
Notifications
Overview
+ New Watchlist
Benzinga Edge
Benzinga Research
Benzinga Pro
Log In
Get Benzinga Pro
Data & APIs
Events
Marketfy
Premarket
Boost
Advertise
Contribute
España
India
Italia
대한민국
日本
Login
Register
Our Services
News
Earnings
Guidance
Dividends
M&A
Buybacks
Legal
Interviews
Management
Offerings
IPOs
Insider Trades
Biotech/FDA
Politics
Healthcare
Markets
Pre-Market
After Hours
Movers
ETFs
Forex
Cannabis
Commodities
Binary Options
Bonds
Futures
CME Group
Global Economics
Mining
Previews
Small-Cap
Real Estate
Penny Stocks
Digital Securities
Volatility
Options
Ratings
Analyst Color
Downgrades
Upgrades
Initiations
Price Target
Ideas
Trade Ideas
Long Ideas
Short Ideas
Technicals
From The Press
Jim Cramer
Rumors
Whisper Index
Stock of the Day
Best Stocks & ETFs
Best Penny Stocks
Best S&P 500 ETFs
Best Swing Trade Stocks
Best Blue Chip Stocks
Best High-Volume Penny Stocks
Best Small Cap ETFs
Best Stocks to Day Trade
Best REITs
Money
Investing
Cryptocurrency
Mortgage
Insurance
Yield
Personal Finance
Forex
Startup Investing
Real Estate Investing
Prop Trading
Credit Cards
Stock Brokers
Crypto
Cannabis
Cannabis Conference
Earnings
Interviews
Deals
Regulations
Psychedelics
Markets
Pre-Market
After Hours
Movers
ETFs
Forex
Cannabis
Commodities
Binary Options
Bonds
Futures
CME Group
Global Economics
Mining
Previews
Small-Cap
Real Estate
Penny Stocks
Digital Securities
Volatility
Options
Ratings
Analyst Color
Downgrades
Upgrades
Initiations
Price Target
Ideas
Trade Ideas
Long Ideas
Short Ideas
Technicals
From The Press
Jim Cramer
Rumors
Whisper Index
Stock of the Day
Best Stocks & ETFs
Best Penny Stocks
Best S&P 500 ETFs
Best Swing Trade Stocks
Best Blue Chip Stocks
Best High-Volume Penny Stocks
Best Small Cap ETFs
Best Stocks to Day Trade
Best REITs
Money
Investing
Cryptocurrency
Mortgage
Insurance
Yield
Personal Finance
Forex
Startup Investing
Real Estate Investing
Prop Trading
Credit Cards
Stock Brokers
Crypto
Cannabis
Cannabis Conference
Earnings
Interviews
Deals
Regulations
Psychedelics
Research
My Stocks
Tools
Free Benzinga Pro Trial
Calendars
Analyst Ratings Calendar
Conference Call Calendar
Dividend Calendar
Earnings Calendar
Economic Calendar
FDA Calendar
Guidance Calendar
IPO Calendar
M&A Calendar
SPAC Calendar
Stock Split Calendar
Trade Ideas
Free Stock Reports
Insider Trades
Trade Idea Feed
Analyst Ratings
Unusual Options Activity
Heatmaps
Free Newsletter
Government Trades
Perfect Stock Portfolio
Easy Income Portfolio
Short Interest
Most Shorted
Largest Increase
Largest Decrease
Calculators
Margin Calculator
Forex Profit Calculator
100x Options Profit Calculator
Recent
Markets
William Blair & Company
William Blair Coughs Up $4.5 Million In SEC Settlement
Shocker: Life-Saving Portable Defibrillator Movement Plagued By Malfunctions
Here's Why Chipotle Looks Poised To Beat Expectations
Shocker: Life-Saving Portable Defibrillator Movement Plagued By Malfunctions
Here's Why Chipotle Looks Poised To Beat Expectations
Under Armour Suits Up For Stock Split
William Blair Sees Significant Opportunity for LinkedIn to Grow in Emerging Markets
Under Armour Suits Up For Stock Split
William Blair Sees Significant Opportunity for LinkedIn to Grow in Emerging Markets
UPDATE: William Blair & Company Upgrades Sonic Following Investor Meetings with Management
UPDATE: William Blair & Company Upgrades WABCO on Multiple Positive Factors
Read More...
William Blair & Company Recent News
Starbucks Looks Toward Franchise Strategy to Caffeinate European Business
UPDATE: William Blair & Company Initiates Coverage on Zoetis on Good Earnings Growth Potential
UPDATE: William Blair & Company Initiates Coverage on Criteo SA on Positive Outlook
UPDATE: William Blair & Company Downgrades GSE Holding Following Below-Expectations 3Q 2013 Revenue/Earnings
William Blair & Company Reiterates on 3D Systems Following Recovery After 3Q Report
William Blair Reiterates Outperform on Teradata Following Preliminary 3Q Results
William Blair Reiterates Outperform Rating on Facebook Following Company/Investor Meetings
William Blair Reiterates Outperform on Nektar Therapeutics Following NKTR-181 Phase 2 Trial Miss
UPDATE: William Blair Downgrades Greenway Medical Technologies Following Announcement of Acquisition by Vista Equity Partners
UPDATE: William Blair Initiates Coverage on Infinity Pharmaceuticals on Multiple Challenges Ahead
UPDATE: William Blair Initiates Coverage on Pharmacyclics on Good Market Position for Ibrutinib
UPDATE: William Blair Upgrades SciQuest Following Executive Meetings
UPDATE: William Blair Downgrades Molex to Market Perform Following Announcement of Acquisition by Koch Brothers
UPDATE: William Blair Downgrades WABCO Holdings to Market Perform, Reiterates $65 PT
William Blair Reiterates Outperform Rating on The Cheesecake Factory
William Blair Reiterates Outperform Rating on Rackspace Hosting (RAX)
William Blair Reiterates Outperform Rating on Gartner (IT)
William Blair & Company Adjusts Estimates On Mercury Computer Systems, Inc. (MRCY)
William Blair Reiterates Outperform on DexCom (DXCM)
William Blair Reiterates Market Perform on LECG Corporation (XPRT)
William Blair Reiterates Market Perform Rating on Global Payments (GPN)
William Blair Reiterates Outperform on Euronet Worldwide (EEFT)
Strong Secular Trends and Market Share Gains Lead to Outperform Rating for Manpower Inc. (MAN)